Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide

Saved in:
Bibliographic Details
Main Authors: Aleksandra Berkan-Kawińska, Anna Piekarska, Hanna Berak, Włodzimierz Mazur, Aleksander Garlicki, Magdalena Tudrujek-Zdunek, Beata Lorenc, Dorota Dybowska, Łukasz Socha, Anna Parfieniuk-Kowerda, Robert Flisiak
Format: Article
Language:English
Published: Termedia Publishing House 2024-07-01
Series:Clinical & Experimental Hepatology
Subjects:
Online Access:https://www.termedia.pl/Effectiveness-of-glecaprevir-pibrentasvir-in-HIV-HCV-coinfected-patients-treated-with-bictegravir-emtricitabine-tenofovir-alafenamide,80,54512,1,1.html
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832584882178490368
author Aleksandra Berkan-Kawińska
Anna Piekarska
Hanna Berak
Włodzimierz Mazur
Aleksander Garlicki
Magdalena Tudrujek-Zdunek
Beata Lorenc
Dorota Dybowska
Łukasz Socha
Anna Parfieniuk-Kowerda
Robert Flisiak
author_facet Aleksandra Berkan-Kawińska
Anna Piekarska
Hanna Berak
Włodzimierz Mazur
Aleksander Garlicki
Magdalena Tudrujek-Zdunek
Beata Lorenc
Dorota Dybowska
Łukasz Socha
Anna Parfieniuk-Kowerda
Robert Flisiak
author_sort Aleksandra Berkan-Kawińska
collection DOAJ
format Article
id doaj-art-aeb1d1e4a819420ea3a53adabfb7066a
institution Kabale University
issn 2392-1099
2449-8238
language English
publishDate 2024-07-01
publisher Termedia Publishing House
record_format Article
series Clinical & Experimental Hepatology
spelling doaj-art-aeb1d1e4a819420ea3a53adabfb7066a2025-01-27T10:31:04ZengTermedia Publishing HouseClinical & Experimental Hepatology2392-10992449-82382024-07-0110316516910.5114/ceh.2024.14175254512Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamideAleksandra Berkan-KawińskaAnna PiekarskaHanna BerakWłodzimierz MazurAleksander GarlickiMagdalena Tudrujek-ZdunekBeata LorencDorota DybowskaŁukasz SochaAnna Parfieniuk-KowerdaRobert Flisiakhttps://www.termedia.pl/Effectiveness-of-glecaprevir-pibrentasvir-in-HIV-HCV-coinfected-patients-treated-with-bictegravir-emtricitabine-tenofovir-alafenamide,80,54512,1,1.htmlhiv/hcv coinfection daa treatment glecaprevir/pibrentasvir bictegravir/emtricitabine/tenofovir alafenamide
spellingShingle Aleksandra Berkan-Kawińska
Anna Piekarska
Hanna Berak
Włodzimierz Mazur
Aleksander Garlicki
Magdalena Tudrujek-Zdunek
Beata Lorenc
Dorota Dybowska
Łukasz Socha
Anna Parfieniuk-Kowerda
Robert Flisiak
Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide
Clinical & Experimental Hepatology
hiv/hcv coinfection
daa treatment
glecaprevir/pibrentasvir
bictegravir/emtricitabine/tenofovir alafenamide
title Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide
title_full Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide
title_fullStr Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide
title_full_unstemmed Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide
title_short Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide
title_sort effectiveness of glecaprevir pibrentasvir in hiv hcv coinfected patients treated with bictegravir emtricitabine tenofovir alafenamide
topic hiv/hcv coinfection
daa treatment
glecaprevir/pibrentasvir
bictegravir/emtricitabine/tenofovir alafenamide
url https://www.termedia.pl/Effectiveness-of-glecaprevir-pibrentasvir-in-HIV-HCV-coinfected-patients-treated-with-bictegravir-emtricitabine-tenofovir-alafenamide,80,54512,1,1.html
work_keys_str_mv AT aleksandraberkankawinska effectivenessofglecaprevirpibrentasvirinhivhcvcoinfectedpatientstreatedwithbictegraviremtricitabinetenofoviralafenamide
AT annapiekarska effectivenessofglecaprevirpibrentasvirinhivhcvcoinfectedpatientstreatedwithbictegraviremtricitabinetenofoviralafenamide
AT hannaberak effectivenessofglecaprevirpibrentasvirinhivhcvcoinfectedpatientstreatedwithbictegraviremtricitabinetenofoviralafenamide
AT włodzimierzmazur effectivenessofglecaprevirpibrentasvirinhivhcvcoinfectedpatientstreatedwithbictegraviremtricitabinetenofoviralafenamide
AT aleksandergarlicki effectivenessofglecaprevirpibrentasvirinhivhcvcoinfectedpatientstreatedwithbictegraviremtricitabinetenofoviralafenamide
AT magdalenatudrujekzdunek effectivenessofglecaprevirpibrentasvirinhivhcvcoinfectedpatientstreatedwithbictegraviremtricitabinetenofoviralafenamide
AT beatalorenc effectivenessofglecaprevirpibrentasvirinhivhcvcoinfectedpatientstreatedwithbictegraviremtricitabinetenofoviralafenamide
AT dorotadybowska effectivenessofglecaprevirpibrentasvirinhivhcvcoinfectedpatientstreatedwithbictegraviremtricitabinetenofoviralafenamide
AT łukaszsocha effectivenessofglecaprevirpibrentasvirinhivhcvcoinfectedpatientstreatedwithbictegraviremtricitabinetenofoviralafenamide
AT annaparfieniukkowerda effectivenessofglecaprevirpibrentasvirinhivhcvcoinfectedpatientstreatedwithbictegraviremtricitabinetenofoviralafenamide
AT robertflisiak effectivenessofglecaprevirpibrentasvirinhivhcvcoinfectedpatientstreatedwithbictegraviremtricitabinetenofoviralafenamide